1. Home
  2. MOH vs ALKS Comparison

MOH vs ALKS Comparison

Compare MOH & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molina Healthcare Inc

MOH

Molina Healthcare Inc

HOLD

Current Price

$197.37

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$44.18

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOH
ALKS
Founded
1980
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
8.7B
IPO Year
2002
2012

Fundamental Metrics

Financial Performance
Metric
MOH
ALKS
Price
$197.37
$44.18
Analyst Decision
Hold
Buy
Analyst Count
13
14
Target Price
$167.00
$43.43
AVG Volume (30 Days)
437.6K
1.3M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.46
N/A
Revenue
$45,426,000,000.00
$1,475,899,000.00
Revenue This Year
$2.40
$24.26
Revenue Next Year
$5.18
$4.47
P/E Ratio
$137.99
N/A
Revenue Growth
11.75
N/A
52 Week Low
$121.06
$26.99
52 Week High
$244.89
$55.67

Technical Indicators

Market Signals
Indicator
MOH
ALKS
Relative Strength Index (RSI) 45.24 36.04
Support Level $196.50 $36.25
Resistance Level $204.11 $51.25
Average True Range (ATR) 6.39 1.44
MACD 0.08 -0.15
Stochastic Oscillator 35.10 20.44

Price Performance

Historical Comparison
MOH
ALKS

About MOH Molina Healthcare Inc

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: